Fear sells (vaccines). Thus, the perpetual state of emergency continues.
President Biden just extended the Covid public health “emergency” for the 12th time - this time through April.
And now here come the RSV emergencies…






For people who have been paying close attention, this is looking very familiar.
Southern California’s Orange County Health Department this month declared a local health emergency over concerns around the rising number of pediatric cases of Respiratory Syncytial Virus (RSV).
County officials also declared a Proclamation of Local Emergency,allowing them to access state and federal resources in response to the spread of RSV.
The news came amid media warnings of a looming “tripledemic” of RSV, influenza and COVID-19 and news that Pfizer and GlaxoSmithKline (GSK) are close to securing regulatory approval for their RSV vaccine candidates — including Pfizer’s RSV vaccine for pregnant women.
For a detailed explanation of the playbook, you will want to watch The Real Anthony Fauci.
Celia Farber can speak to the playbook perhaps better than anyone.
You’ll likely be hearing a lot about crowded hospitals and sick children. What you are much less likely to hear is the potential impact of COVID shot mandates on hospital staff shortages. Many hospitals fired healthy, unvaccinated staff members and are now understaffed.

Mainstream media will probably not be discussing “immunity debt"…
Nevertheless, concerns have been raised about the potential for more severe RSV epidemics in the future due to a so-called immunity debt, a term proposed to describe the paucity of protective immunity arising from extended periods of low exposure to a given pathogen, leaving a greater proportion of the population susceptible to the disease. This immunity debt is a particular concern for RSV, for which temporary immunity is obtained through exposure to the virus and maternal antibodies wane quickly; without seasonal exposure, immunity decreases and susceptibility to future, and potentially more severe, infection increases. (emphasis mine)
You’re also not likely to hear about incriminating clinical trial data that showed elevated rates of RSV in children who received COVID shots (vs. placebo).


See how this aligns with your definition of insanity…
As reported on The HighWire last week, there has been an alarming spike in reported cases of Respiratory Syncytial Virus (RSV) in children. This influenza-like virus can be particularly dangerous in very young children and it typically rises in the winter months. What makes the current spike particularly alarming is that it is occurring off-season.
On the HighWire episode, Del did a deep dive into the issue, observing that in the clinical trial for Moderna’s pediatric Covid-19 vaccine, the children who received the vaccine experienced higher rates of RSV than those receiving the placebo. Similarly, in Pfizer’s pediatric Covid-19 vaccine trial, RSV was listed as one of the serious adverse events among children receiving this vaccine.
The issue is so serious that even the FDA’s vaccine committee, VRBPAC, which normally cheerleads even the most dangerous vaccine, noted the correlation and “stressed the importance of continued post-authorization safety surveillance, in particular for … certain respiratory infections (RSV and pneumonia) in the youngest age group, for which imbalances of uncertain clinical significance were observed in the clinical trial.”
Despite the noted importance of surveilling RSV post-authorization, no one at CDC or FDA seems to be drawing a connection between the increase in RSV and the Covid-19 vaccines being administered to children. Incredibly, the CDC just issued an “Official Health Advisory” about the increase RSV and respiratory virus cases and, in it, the CDC recommends all individuals 6 months and up receive an influenza vaccine and a Covid-19 vaccine!


Many of us are wondering why health departments, which generally LOVE tracking vaccine status, are not doing so when it comes to RSV cases subsequent to COVID shots. Attorney Aaron Siri is not waiting around for regulatory authorities to do their jobs. If you have an experience to share, e-mail ebrehm@sirilp.com

Meanwhile, it’s a good time to get familiar with other information about Respiratory Syncytial Virus…



It’s also a good time to revisit the track record of previous RSV vaccine attempts, as well as the concept of antibody-dependent enhancement (ADE).







Let’s not be fooled again, please.
https://twitter.com/IamBrookJackson/status/1589905148838838273
Sadly at this point in time, I will never ever trust any politicians or health care professionals again. We will never get the real truth from them...